RANBAXY LABORATORIES LTD. - OHM Laboratories to launch Valsartan Tablets - Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure
Download 
|
< Back |
| 27 Jun 2014 | |
| Ranbaxy Laboratories Ltd has submitted to BSE a copy of Press Release titled OHM Laboratories to launch Valsartan Tablets - Receives first-to-file FDA approval, with 180-day marketing exclusivity for generic version in the treatment of hypertension and heart failure" which has been issued by Ohm Laboratories Inc, a wholly owned subsidiary of the Company. | |
| View all announcements for RANBAXY LABORATORIES LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback